2o3p: Difference between revisions
New page: left|200px<br /> <applet load="2o3p" size="450" color="white" frame="true" align="right" spinBox="true" caption="2o3p, resolution 2.24Å" /> '''Crystal structure o... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2o3p.gif|left|200px]]<br /> | [[Image:2o3p.gif|left|200px]]<br /><applet load="2o3p" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2o3p" size=" | |||
caption="2o3p, resolution 2.24Å" /> | caption="2o3p, resolution 2.24Å" /> | ||
'''Crystal structure of Pim1 with Quercetin'''<br /> | '''Crystal structure of Pim1 with Quercetin'''<br /> | ||
==Overview== | ==Overview== | ||
The pim-1 kinase is a true oncogene that has been implicated in the | The pim-1 kinase is a true oncogene that has been implicated in the development of leukemias, lymphomas, and prostate cancer, and is the target of drug development programs. We have used experimental approaches to identify a selective, cell-permeable, small-molecule inhibitor of the pim-1 kinase to foster basic and translational studies of the enzyme. We used an ELISA-based kinase assay to screen a diversity library of potential kinase inhibitors. The flavonol quercetagetin (3,3',4',5,6,7-hydroxyflavone) was identified as a moderately potent, ATP-competitive inhibitor (IC(50), 0.34 micromol/L). Resolution of the crystal structure of PIM1 in complex with quercetagetin or two other flavonoids revealed a spectrum of binding poses and hydrogen-bonding patterns in spite of strong similarity of the ligands. Quercetagetin was a highly selective inhibitor of PIM1 compared with PIM2 and seven other serine-threonine kinases. Quercetagetin was able to inhibit PIM1 activity in intact RWPE2 prostate cancer cells in a dose-dependent manner (ED(50), 5.5 micromol/L). RWPE2 cells treated with quercetagetin showed pronounced growth inhibition at inhibitor concentrations that blocked PIM1 kinase activity. Furthermore, the ability of quercetagetin to inhibit the growth of other prostate epithelial cell lines varied in proportion to their levels of PIM1 protein. Quercetagetin can function as a moderately potent and selective, cell-permeable inhibitor of the pim-1 kinase, and may be useful for proof-of-concept studies to support the development of clinically useful PIM1 inhibitors. | ||
==About this Structure== | ==About this Structure== | ||
2O3P is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with IMD and QUE as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http:// | 2O3P is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=IMD:'>IMD</scene> and <scene name='pdbligand=QUE:'>QUE</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2O3P OCA]. | ||
==Reference== | ==Reference== | ||
Line 17: | Line 16: | ||
[[Category: Bremer, R.]] | [[Category: Bremer, R.]] | ||
[[Category: Holder, S.]] | [[Category: Holder, S.]] | ||
[[Category: Lilly, M | [[Category: Lilly, M B.]] | ||
[[Category: Neidigh, J | [[Category: Neidigh, J W.]] | ||
[[Category: Tabrizizad, M.]] | [[Category: Tabrizizad, M.]] | ||
[[Category: Zemskova, M.]] | [[Category: Zemskova, M.]] | ||
Line 27: | Line 26: | ||
[[Category: quercetin]] | [[Category: quercetin]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:14:07 2008'' |